POLYCORE THERAPEUTICS
PolyCore Therapeutics’ experienced team of scientists and life sciences professionals is dedicated to developing breakthrough treatments for CNS Diseases.
POLYCORE THERAPEUTICS
Industry:
Health Care Professional Services Therapeutics
Founded:
2015-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.polycoretherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Euro Mobile Non Scaleable Content Google Adsense AdBlock Acceptable Ads Google Adsense For Domains SEDO DNS
Similar Organizations
AvenCell
Based on our deep science and focused on patients in need.
Azenta Life Sciences
Azenta Life Sciences provides life sciences solutions.
Ceribell
Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective.
Aitia
Leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs
Inceptive
Inceptive Designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.
NeuroTracker
NeuroTracker is a neurotech company specializing in assessing and enhancing cognitive functions for human performance and wellness.
Openwater
Openwater is a San Francisco-based startup focused on devising a new generation of imaging technologies for brain computer interfaces.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Synapticure
We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
Current Advisors List
Current Employees Featured
Founder
Investors List
Xontogeny
Xontogeny investment in Seed Round - PolyCore Therapeutics
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - PolyCore Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - PolyCore Therapeutics
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - PolyCore Therapeutics
Official Site Inspections
http://www.polycoretherapeutics.com Semrush global rank: 12.81 M Semrush visits lastest month: 79
- Host name: 64.190.63.222
- IP address: 64.190.63.222
- Location: Cleveland United States
- Latitude: 41.5043
- Longitude: -81.6786
- Metro Code: 510
- Timezone: America/New_York
- Postal: 44114
More informations about "PolyCore Therapeutics"
PolyCore Therapeutics - Crunchbase Company Profile …
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.See details»
PolyCore Therapeutics LLC - VentureRadar
"PolyCore Therapeutics is a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders.See details»
PolyCore Therapeutics - Overview, News & Similar companies
Apr 11, 2022 Who is PolyCore Therapeutics. PolyCore Therapeutics, Inc. is a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive …See details»
PolyCore Therapeutics - PitchBook
Deal Type Date Amount Raised to Date Post-Val Status Stage; 12. Later Stage VC: Upcoming: Pre-Clinical Trials: 11. Secondary Transaction - Private: 01-Sep-2022See details»
PolyCore Therapeutics Company Profile | Management and
[email protected]: PolyCore Therapeutics Top Competitors. Company Employees Revenue Top technologies; Neuropore Therapies Inc. 16: $4.1 M: Collaborative …See details»
PolyCore Therapeutics, Inc. | LinkedIn
PolyCore Therapeutics was a preclinical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders.See details»
Polycore Therapeutics Llc. Company Profile - Dun & Bradstreet
Address: 3180 Chestnut St Ste 104 Philadelphia, PA, 19104-3282 United StatesSee details»
Polycore Therapeutics Llc. Company Profile - Dun & Bradstreet
Polycore Therapeutics Llc. Company Profile | Philadelphia, PA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Polycore Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Polycore Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Nervous ...See details»
PolyCore Therapeutics - Craft
PolyCore Therapeutics is a biopharmaceutical company developing treatments for dyskinesia and cognitive impairment associated with neurodegenerative disorders.See details»
Polycore Therapeutics LLC Details - govtribe.com
- https://polycoretherapeutics.com. Twitter PolyCore Therapeutics is a biopharma company developing treatments for patients suffering from dyskinesia and cognitive impairment …See details»
PolyCore Therapeutics - Products, Competitors, Financials, …
Headquarters Location. Left Bank Office of Drexel University 3180 Chestnut St, Ste 104. Philadelphia, Pennsylvania, 19104, United States. 484-888-2661See details»
PolyCore Therapeutics, Inc. Overview | SignalHire Company Profile
PolyCore Therapeutics, Inc. headquarters is in Philadelphia, PA. PolyCore Therapeutics, Inc. is in the sectors of: Biotech. To connect with PolyCore Therapeutics, Inc.'s employee register on …See details»
PolyCore Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View PolyCore Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
PolyCore Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
PolyCore Therapeutics LLC is focused on developing treatments …
[email protected] el www.polycoretherapeutics.com • Only company developing novel G protein-biased signaling D3 receptor agonist • PCTis a potential …See details»
Nextsource | Company Profile | PolyCore Therapeutics
Explore the company profile of PolyCore Therapeutics (polycoretherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
PolyCore Therapeutics, Inc. is focused on developing treatments …
Parkinson’s disease • Second most common neurodegenerative disorder affecting >10 million people worldwide; ~1 million in the U.S. • Levodopa (L-dopa) standard of care since 1960sSee details»
PolyCore Therapeutics LLC - Company Profile & Staff Directory
Developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disordersSee details»
PolyCore Therapeutics - Ben Franklin Technology Partners
Ben Franklin Technology Partners of Southeastern Pennsylvania Building 100 Innovation Center 4801 South Broad Street, Suite 200 The Navy Yard, Philadelphia, PA 19112See details»